The impact of the COVID-19 pandemic on antimicrobial resistance: a debate

David van Duin; Gavin Barlow; Dilip Nathwani

doi:10.1093/jacamr/dlaa053

The impact of the COVID-19 pandemic on antimicrobial resistance: a debate

David van Duin (Lead / Corresponding author), Gavin Barlow, Dilip Nathwani

Research output: Contribution to journal › Comment/debate › peer-review

31 Citations (Scopus)

101 Downloads (Pure)

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is having an enormous impact on public health. Infection with SARS-CoV-2 has become a leading cause of morbidity and mortality in many regions around the world. As many COVID-19 patients are treated with antibiotics, there is concern regarding an associated rise in rates of antimicrobial resistance (AMR). On the other hand, social distancing, isolation and reduced travel may result in decreased spread of AMR. In this issue of JAC-Antimicrobial Resistance, we present a PRO/CON debate on the question of the potential impact of COVID-19 on AMR rates.

Original language	English
Article number	dlaa053
Number of pages	2
Journal	JAC-antimicrobial resistance
Volume	2
Issue number	3
Early online date	17 Jul 2020
DOIs	https://doi.org/10.1093/jacamr/dlaa053
Publication status	Published - Sept 2020

Keywords

antibiotics
drug resistance
microbial
travel
infections
morbidity
mortality
public health medicine
antimicrobials
pandemics
sars-cov-2
covid-19
coronavirus pandemic
physical distancing

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jacamr/dlaa053Licence: CC BY

Final Published VersionFinal published version, 155 KBLicence: CC BY

Cite this

@article{143779045f354735a99fd0192afa543d,

title = "The impact of the COVID-19 pandemic on antimicrobial resistance: a debate",

abstract = "The coronavirus disease 2019 (COVID-19) pandemic is having an enormous impact on public health. Infection with SARS-CoV-2 has become a leading cause of morbidity and mortality in many regions around the world. As many COVID-19 patients are treated with antibiotics, there is concern regarding an associated rise in rates of antimicrobial resistance (AMR). On the other hand, social distancing, isolation and reduced travel may result in decreased spread of AMR. In this issue of JAC-Antimicrobial Resistance, we present a PRO/CON debate on the question of the potential impact of COVID-19 on AMR rates.",

keywords = "antibiotics, drug resistance, microbial, travel, infections, morbidity, mortality, public health medicine, antimicrobials, pandemics, sars-cov-2, covid-19, coronavirus pandemic, physical distancing",

author = "{van Duin}, David and Gavin Barlow and Dilip Nathwani",

note = "{\textcopyright} The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.",

year = "2020",

month = sep,

doi = "10.1093/jacamr/dlaa053",

language = "English",

volume = "2",

number = "3",

}

TY - JOUR

T1 - The impact of the COVID-19 pandemic on antimicrobial resistance

T2 - a debate

AU - van Duin, David

AU - Barlow, Gavin

AU - Nathwani, Dilip

N1 - © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

PY - 2020/9

Y1 - 2020/9

N2 - The coronavirus disease 2019 (COVID-19) pandemic is having an enormous impact on public health. Infection with SARS-CoV-2 has become a leading cause of morbidity and mortality in many regions around the world. As many COVID-19 patients are treated with antibiotics, there is concern regarding an associated rise in rates of antimicrobial resistance (AMR). On the other hand, social distancing, isolation and reduced travel may result in decreased spread of AMR. In this issue of JAC-Antimicrobial Resistance, we present a PRO/CON debate on the question of the potential impact of COVID-19 on AMR rates.

AB - The coronavirus disease 2019 (COVID-19) pandemic is having an enormous impact on public health. Infection with SARS-CoV-2 has become a leading cause of morbidity and mortality in many regions around the world. As many COVID-19 patients are treated with antibiotics, there is concern regarding an associated rise in rates of antimicrobial resistance (AMR). On the other hand, social distancing, isolation and reduced travel may result in decreased spread of AMR. In this issue of JAC-Antimicrobial Resistance, we present a PRO/CON debate on the question of the potential impact of COVID-19 on AMR rates.

KW - antibiotics

KW - drug resistance

KW - microbial

KW - travel

KW - infections

KW - morbidity

KW - mortality

KW - public health medicine

KW - antimicrobials

KW - pandemics

KW - sars-cov-2

KW - covid-19

KW - coronavirus pandemic

KW - physical distancing

U2 - 10.1093/jacamr/dlaa053

DO - 10.1093/jacamr/dlaa053

M3 - Comment/debate

C2 - 34192250

SN - 2632-1823

VL - 2

JO - JAC-antimicrobial resistance

JF - JAC-antimicrobial resistance

IS - 3

M1 - dlaa053

ER -

The impact of the COVID-19 pandemic on antimicrobial resistance: a debate

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this